Breaking News Instant updates and real-time market news.

2021-12-06 08:38:10 PRCH Porch Group $17.68 / -1.42 (-7.43%) 08:38 12/06/21 12/06 08:38 12/06/21 08:38	Porch announces newest pay-at-close module for home inspection companies Porch Group announced the addition of a new module to its suite of software solutions provided to home inspection companies through its inspection software business, Inspection Support Network, ISN. Now, Porch can provide agents and homebuyers the ability to pay for their home inspection at the close of a home purchase, in addition to Porch's ability to facilitate the payment processing at the time of inspection. Through the pay-at-close program, ISN will manage the complexity of both providing payment to the inspector at time of inspection, as well as invoice the escrow company on behalf of the homebuyer to defer payment to the close of escrow. "We're always actively exploring every avenue to help home inspection companies grow and stand out from their competition," said Matt Ehrlichman, founder, chairman and CEO of Porch Group. "At the same time by helping homebuyers now pay for their inspections at close, we can make the homebuying experience easier and with less friction for all parties." The program is currently available to select inspection companies and will begin a broad roll-out in 2022.	09 Dec

2021-12-06 08:38:10

PRCH

Porch Group

$17.68 / -1.42 (-7.43%)

08:38

12/06/21

12/06

08:38

12/06/21

08:38

Porch announces newest pay-at-close module for home inspection companies

Porch Group announced the addition of a new module to its suite of software solutions provided to home inspection companies through its inspection software business, Inspection Support Network, ISN. Now, Porch can provide agents and homebuyers the ability to pay for their home inspection at the close of a home purchase, in addition to Porch's ability to facilitate the payment processing at the time of inspection. Through the pay-at-close program, ISN will manage the complexity of both providing payment to the inspector at time of inspection, as well as invoice the escrow company on behalf of the homebuyer to defer payment to the close of escrow. "We're always actively exploring every avenue to help home inspection companies grow and stand out from their competition," said Matt Ehrlichman, founder, chairman and CEO of Porch Group. "At the same time by helping homebuyers now pay for their inspections at close, we can make the homebuying experience easier and with less friction for all parties." The program is currently available to select inspection companies and will begin a broad roll-out in 2022.

09
Dec

OTHER BREAKING NEWS FROM THE FLY

Downgrade	Neurocrine downgraded to Sector Perform from Outperform at RBC Capital » 05:42 01/18/22 01/18 05:42 01/18/22 05:42 NBIX Neurocrine $78.28 / -0.895 (-1.13%) RBC Capital analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly NBIX Neurocrine $78.28 / -0.895 (-1.13%) 01/12/22 Xenon announces collaboration with Neurocrine achieves $15M milestone 01/10/22 Xenon outlines key milestones for 2022 01/06/22 Neurocrine sees Q4 net product sales of Ingressa up 25% to $301M vs. 4Q20 01/06/22 Neurocrine sees Q4 net product sales of Ingressa up 25% to $301M vs. 4Q20 NBIX Neurocrine $78.28 / -0.895 (-1.13%) 12/08/21 Raymond James Raymond James sees 10% rally today for Neurocrine on Ingrezza data 12/08/21 Oppenheimer Neurocrine price target raised to $154 from $140 at Oppenheimer 12/08/21 Citi Neurocrine price target raised to $129 from $127 at Citi 11/18/21 BMO Capital Neurocrine initiated with an Underperform at BMO Capital NBIX Neurocrine $78.28 / -0.895 (-1.13%) 11/01/21 Neurocrine reports Q3 non-GAAP EPS 64c, consensus 60c 08/03/21 Neurocrine reports Q2 non-GAAP EPS 63c, consensus 49c NBIX Neurocrine $78.28 / -0.895 (-1.13%) 12/08/21 Biogen weighs restructuring, had plan to acquire Neurocrine in 2019, STAT says NBIX Neurocrine $78.28 / -0.895 (-1.13%) 01/06/22 Fly Intel: After-Hours Movers 11/17/21 Wall Street in Fives - Must Read Lists for Wednesday 11/17/21 Wall Street in Fives - Must Read Lists at Midday 11/01/21 Fly Intel: After-Hours Movers
Upgrade	Incyte upgraded to Outperform from Sector Perform at RBC Capital » 05:41 01/18/22 01/18 05:41 01/18/22 05:41 INCY Incyte $74.90 / +1.3 (+1.77%) RBC Capital analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options INCY Incyte $74.90 / +1.3 (+1.77%) 12/14/21 Incyte says FDA accepts ruxolitinib cream sNDA for priority review 12/12/21 MorphoSys, Incyte announce additional real-world evidence results from RE-MIND2 12/12/21 Incyte announces data from three ongoing Phase 2 studies evaluating parsaclisib 12/02/21 Merus announces poster presentation on MCLA-145 at ESMO-IO INCY Incyte $74.90 / +1.3 (+1.77%) 01/03/22 Guggenheim Incyte price target lowered to $104 from $118 at Guggenheim 12/31/21 Benchmark Incyte, Nektar, Compass Therapeutics named best biotech picks at Benchmark 11/18/21 BMO Capital Incyte initiated with a Market Perform at BMO Capital 10/15/21 Cantor Fitzgerald Incyte price target lowered to $79 from $104 at Cantor Fitzgerald INCY Incyte $74.90 / +1.3 (+1.77%) 11/09/21 Eli Lilly and Incyte presents results from Olumiant study 11/02/21 Incyte reports Q3 EPS $1.18, consensus 74c 08/03/21 Incyte reports Q2 EPS 80c, consensus 75c INCY Incyte $74.90 / +1.3 (+1.77%) 12/31/21 Wall Street in Fives - Must Read Lists for Friday 12/31/21 Wall Street in Fives - Must Read Lists at Midday 12/20/21 Fly Insider: Venus Concept, Alpha & Omega among week's notable insider trades 09/22/21 Wall Street in Fives - Must Read Lists for Wednesday 01/20/22 ASCO Gastrointestinal Cancers Symposium 02/02/22 Transplantation & Cellular Therapy Meetings of ASTCT & CIBMTR 06/03/22 2022 ASCO Annual Meeting 04/30/22 PDUFA Date for Parsaclisib INCY Incyte $74.90 / +1.3 (+1.77%) 12/31/21 Early notable gainers among liquid option names on December 31st 11/03/21 Early notable gainers among liquid option names on November 3rd 09/20/21 Early notable gainers among liquid option names on September 20th
Hot Stocks	Sonida Senior Living announces December occupancy » 05:41 01/18/22 01/18 05:41 01/18/22 05:41 SNDA Sonida Senior Living $30.00 / +1 (+3.45%) Sonida Senior Living… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events SNDA Sonida Senior Living $30.00 / +1 (+3.45%) 12/30/21 Sonida Senior Living rises 7.4% 12/28/21 Sonida Senior Living rises 7.7% 12/16/21 Sonida Senior Living acquires two senior living communities for $12.3M 12/14/21 Sonida Senior Living falls -26.2% 01/27/22 Sonida Senior Living Inc
Upgrade	Six Flags upgraded to Outperform from Perform at Oppenheimer » 05:39 01/18/22 01/18 05:39 01/18/22 05:39 SIX Six Flags $40.65 / -0.87 (-2.10%) Oppenheimer analyst Ian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SIX Six Flags $40.65 / -0.87 (-2.10%) 11/15/21 Six Flags CEO Michael Spanos steps down, Selim Bassoul succeeds 10/27/21 Six Flags falls -8.4% 10/06/21 Six Flags partners with Clear Secure for proof of vaccination at Magic Mountain 09/07/21 Volta partners with Six Flags for electric vehicle charging SIX Six Flags $40.65 / -0.87 (-2.10%) 12/17/21 Credit Suisse Six Flags upgraded to Outperform from Neutral at Credit Suisse 12/14/21 Goldman Sachs Six Flags upgraded to Buy at Goldman after leisure group correction 12/14/21 Goldman Sachs Six Flags upgraded to Buy from Neutral at Goldman Sachs 11/17/21 Fly Intel: Top five analyst initiations SIX Six Flags $40.65 / -0.87 (-2.10%) 10/27/21 Six Flags reports Q3 EPS $1.80, consensus $1.55 10/26/21 Notable companies reporting before tomorrow's open 10/26/21 Notable companies reporting before tomorrow's open 07/28/21 Six Flags reports Q2 EPS 81c, consensus (7c) SIX Six Flags $40.65 / -0.87 (-2.10%) 07/19/21 Chemical incident occurs at Six Flags waterpark in Texas, CBS News reports SIX Six Flags $40.65 / -0.87 (-2.10%) 12/17/21 Wall Street in Fives - Must Read Lists for Friday 12/17/21 Wall Street in Fives - Must Read Lists at Midday 12/17/21 Six Flags upgrade, Starbucks downgrade among today's top calls on Wall Street 12/14/21 Fly Intel: After-Hours Movers
Downgrade	Sportradar downgraded to Equal Weight from Overweight at Morgan Stanley » 05:38 01/18/22 01/18 05:38 01/18/22 05:38 SRAD Sportradar $15.47 / -0.07 (-0.45%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options SRAD Sportradar $15.47 / -0.07 (-0.45%) 12/22/21 Sportradar, Bundesliga announce five-year extension of partnership 12/15/21 Sportradar appoints Rima Hyder as Head of Investor Relations 12/12/21 Fly Intel: Top five weekend stock stories 12/01/21 Sportradar, PointsBet announce new multi-year sports betting partnership SRAD Sportradar $15.47 / -0.07 (-0.45%) 01/04/22 Craig-Hallum Sportradar price target lowered to $30 from $35 at Craig-Hallum 11/18/21 Deutsche Bank Sportradar price target lowered to $27 from $28 at Deutsche Bank 11/18/21 Citi Sportradar price target lowered to $28 from $30 at Citi 10/11/21 Fly Intel: Top five analyst initiations SRAD Sportradar $15.47 / -0.07 (-0.45%) 11/17/21 Sportradar sees FY21 revenue EUR 553M - EUR 555M 11/17/21 Sportradar reports Q3 revenue EUR 136.8M vs. EUR 105.3M last year 14 Sep SRAD Sportradar $15.47 / -0.07 (-0.45%) 12/11/21 Sportradar betting on sports betting data, Barron's says 08/19/21 Sportradar and FanDuel extend data partnership, CNBC reports SRAD Sportradar $15.47 / -0.07 (-0.45%) 01/07/22 Bet On It: New York ushers in mobile sports betting in time for NFL playoffs 12/23/21 Bet On It: Ohio sports betting officially legalized 10/15/21 Bet On It: Promotions put profit on back burner in hopes for customer retention 10/11/21 Starbucks upgrade, DraftKings initiation among today's top calls on Wall Street SRAD Sportradar $15.47 / -0.07 (-0.45%) 09/22/21 Eleven new option listings and one option delisting on September 22nd

Downgrade	Choice Hotels downgraded to Underweight from Equal Weight at Morgan Stanley » 05:38 01/18/22 01/18 05:38 01/18/22 05:38 CHH Choice Hotels $152.05 / -1.76 (-1.14%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CHH Choice Hotels $152.05 / -1.76 (-1.14%) 12/06/21 Choice Hotels boosts quarterly dividend by 6% to 23.75c per share 11/04/21 Choice Hotels sees 2021 domestic RevPAR 1% above 2019 10/25/21 Choice Hotels announces new corporate headquarters in North Bethesda, MD 08/05/21 Choice Hotels sees 2021 adjusted EBITDA approaching 2019 levels CHH Choice Hotels $152.05 / -1.76 (-1.14%) 12/03/21 Truist Choice Hotels price target raised to $125 from $114 at Truist 12/02/21 Fly Intel: Top five analyst downgrades 12/02/21 Loop Capital Choice Hotels downgraded to Hold from Buy at Loop Capital 11/17/21 Fly Intel: Top five analyst downgrades CHH Choice Hotels $152.05 / -1.76 (-1.14%) 11/04/21 Choice Hotels reports Q3 adjusted EPS $1.51, consensus $1.36 08/05/21 Choice Hotels reports Q2 EPS $1.53, consensus 88c 01/24/22 ALIS 2022
Upgrade	Johnson Matthey upgraded to Hold from Sell at Panmure Gordon » 05:37 01/18/22 01/18 05:37 01/18/22 05:37 JMPLY Johnson Matthey $53.97 / -0.93 (-1.69%) Panmure Gordon analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research JMPLY Johnson Matthey $53.97 / -0.93 (-1.69%) 07/28/21 Johnson Matthey acquires assets, IP of Oxis Energy Limited JMPLY Johnson Matthey $53.97 / -0.93 (-1.69%) 01/14/22 Barclays Johnson Matthey price target lowered to 2,320 GBp from 2,510 GBp at Barclays 01/13/22 JPMorgan Johnson Matthey price target lowered to 2,600 GBp from 2,800 GBp at JPMorgan 01/06/22 Bernstein Johnson Matthey downgraded to Market Perform from Outperform at Bernstein 12/02/21 Stifel Johnson Matthey upgraded to Buy from Hold at Stifel
Hot Stocks	Ionis Pharmaceuticals partner Roche to design new tominersen trial » 05:36 01/18/22 01/18 05:36 01/18/22 05:36 IONS Ionis Pharmaceuticals $33.07 / +0.895 (+2.78%) , RHHBY Roche $50.30 / +0.82 (+1.66%) Ionis Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events IONS RHHBY IONS Ionis Pharmaceuticals $33.07 / +0.895 (+2.78%) 01/06/22 Ionis Pharmaceuticals' eplontersen granted FDA orphan designation 01/04/22 Biogen exercises option with Ionis to develop, commercialize ASO for SMA 01/04/22 Biogen exercises option with Ionis to develop, commercialize BIIB115/ION306 12/29/21 Ionis Pharmaceuticals, AstraZeneca close deal to develop commercial eplontersen RHHBY Roche $50.30 / +0.82 (+1.66%) 01/14/22 Roche awarded $340M Army contract for COVID-19 rapid antigen tests 01/12/22 Mainz Biomed names Michele Pedrocchi to strategic advisory board 01/05/22 Rain Therapeutics, Roche to collaborate on trial of milademetan combination 12/26/21 Fly Intel: Top five weekend stock stories IONS RHHBY IONS Ionis Pharmaceuticals $33.07 / +0.895 (+2.78%) 12/28/21 Oppenheimer Ionis weakness associated with peer ATTR failure 'misplaced,' says Oppenheimer 12/14/21 William Blair Ionis upgraded to Outperform on pipeline opportunities at William Blair 12/14/21 William Blair Ionis Pharmaceuticals upgraded to Outperform from Market Perform at William Blair 11/26/21 Mizuho Pfizer data on vupanorsen is mixed, says Mizuho RHHBY Roche $50.30 / +0.82 (+1.66%) 01/14/22 BofA Biogen price target lowered to $245 from $275 at BofA 01/04/22 JPMorgan Roche price target raised to CHF 390 from CHF 360 at JPMorgan 12/22/21 Citi Roche resumed with a Buy at Citi 12/13/21 Credit Suisse Roche price target raised to CHF 370 from CHF 350 at Credit Suisse IONS RHHBY IONS Ionis Pharmaceuticals $33.07 / +0.895 (+2.78%) 11/03/21 Ionis Pharmaceuticals reports Q3 EPS (58c), consensus (52c) 08/04/21 Ionis Pharmaceuticals sees FY21 net loss less than ($110M) 08/04/21 Ionis Pharmaceuticals reports Q2 EPS (57c), consensus (58c) RHHBY Roche $50.30 / +0.82 (+1.66%) 10/20/21 Roche reports 9M group sales CHF 46.68B vs. CHF 43.98B last year 07/22/21 Roche reports 1H21 core EPS CHF10.56 vs. CHF10.44 last year RHHBY RHHBY Roche $50.30 / +0.82 (+1.66%) 12/20/21 Roche's Genentech to license rights to Lineage eye drug, WSJ reports 11/12/21 Biden to nominate Robert Califf to lead FDA, Politico reports 11/03/21 Democrats reach agreement to lower prescription prices, WSJ reports 10/28/21 Aurinia Pharmaceuticals up 4% after Betaville issues 'Rare Alert' RHHBY RHHBY Roche $50.30 / +0.82 (+1.66%) 01/13/22 Meet Prothena: Fly exclusive interview with CEO Gene Kinney 11/16/21 Fly Intel: After-Hours Movers 09/27/21 Acceleron up amid report of talks, Cowen says $180 per share 'too low' a price 09/07/21 Wall Street in Fives - Must Read Lists for Tuesday 01/29/22 PDUFA Date for Faricimab
Upgrade	Siltronic upgraded to Outperform from Neutral at Oddo BHF » 05:35 01/18/22 01/18 05:35 01/18/22 05:35 SSLLF Siltronic $153.65 / + (+0.00%) Oddo BHF analyst Stephane… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SSLLF Siltronic $153.65 / + (+0.00%) 02/02/21 Berenberg Siltronic price target raised to EUR 145 from EUR 125 at Berenberg 01/26/21 Deutsche Bank Siltronic downgraded to Hold from Buy at Deutsche Bank 01/26/21 Stifel Siltronic downgraded to Hold from Buy at Stifel 01/22/21 Oddo BHF Siltronic downgraded to Neutral from Buy at Oddo BHF
Initiation	Daimler Truck Holding initiated with a Buy at DZ Bank » 05:35 01/18/22 01/18 05:35 01/18/22 05:35 DTRUY Daimler Truck Holding $20.11 / +0.71 (+3.66%) DZ Bank initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research DTRUY Daimler Truck Holding $20.11 / +0.71 (+3.66%) 12/16/21 Volvo, Daimler Truck and Traton to create public charging network JV in Europe DTRUY Daimler Truck Holding $20.11 / +0.71 (+3.66%) 01/10/22 Stifel Daimler Truck Holding initiated with a Buy at Stifel 01/04/22 RBC Capital Daimler Truck Holding initiated with an Outperform at RBC Capital 12/13/21 Citi Daimler Truck Holding initiated with a Buy at Citi

General news	FX Action: USD-JPY » 05:35 01/18/22 01/18 05:35 01/18/22 05:35 $ECON Economic Data / + FX Action: USD-JPY is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly $ECON Economic Data / + 09/27/21 Rob Kaplan to retire as Dallas Fed President $ECON Economic Data / + $ECON Economic Data / + 10/26/21 Democrats considering 3% 'surtax' on millionaires, WaPo reports 09/22/21 Federal Reserve keeps interest rate benchmark unchanged at 0%-0.25% $ECON Economic Data / + 12/15/21 Wall Street in Fives - Must Read Lists for Wednesday 11/30/21 Wall Street in Fives - Must Read Lists for Tuesday 11/03/21 Wall Street in Fives - Must Read Lists for Wednesday
Upgrade	Zscaler upgraded to Overweight from Equal Weight at Morgan Stanley » 05:34 01/18/22 01/18 05:34 01/18/22 05:34 ZS Zscaler $254.94 / +4.57 (+1.83%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ZS Zscaler $254.94 / +4.57 (+1.83%) 12/22/21 Zscaler officer Rajic sells $7.9M in company shares 12/20/21 Zscaler CFO sells $4.47M in common stock 11/30/21 Zscaler up 4.3% after reporting Q1 earnings, giving Q2, FY22 guidance 11/18/21 Zscaler powers its global data centers, offices with 100% renewable energy ZS Zscaler $254.94 / +4.57 (+1.83%) 01/10/22 UBS Zscaler upgraded to Buy from Neutral at UBS 01/06/22 Piper Sandler Zscaler price target lowered to $295 from $365 at Piper Sandler 01/05/22 Wells Fargo Zscaler initiated with an Overweight at Wells Fargo 12/15/21 Mizuho Zscaler price target lowered to $385 from $400 at Mizuho ZS Zscaler $254.94 / +4.57 (+1.83%) 11/30/21 Zscaler sees FY22 EPS 50c-52c, consensus 56c 11/30/21 Zscaler sees Q2 EPS approximately 11c, consensus 12c 11/30/21 Zscaler reports Q1 EPS 14c, consensus 12c 11/30/21 Notable companies reporting after market close ZS Zscaler $254.94 / +4.57 (+1.83%) 12/01/21 Wall Street in Fives - Must Read Lists for Wednesday 12/01/21 Wall Street in Fives - Must Read Lists at Midday 11/30/21 Fly Intel: After-Hours Movers 11/16/21 Microsoft assumption, PayPal initiation among today's top calls on Wall Street ZS Zscaler $254.94 / +4.57 (+1.83%) 01/13/22 Zscaler put volume heavy and directionally bearish 11/30/21 Zscaler options imply 8.8% move in share price post-earnings 09/09/21 Zscaler options imply 10.5% move in share price post-earnings
Upgrade	Indutrade upgraded to Buy from Hold at Danske Bank » 05:34 01/18/22 01/18 05:34 01/18/22 05:34 IDDWF Indutrade $58.92 / + (+0.00%) Danske Bank analyst Johan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Molecular Partners, Novartis enter ensovibep license agreement » 05:33 01/18/22 01/18 05:33 01/18/22 05:33 MOLN Molecular Partners $31.61 / +3.515 (+12.51%) , NVS Novartis $90.53 / -0.09 (-0.10%) Molecular Partners (MOLN)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MOLN NVS MOLN Molecular Partners $31.61 / +3.515 (+12.51%) 01/10/22 Molecular Partners, Novartis report Part A of EMPATHY trial met primary endpoint 12/12/21 Molecular Partners confirms ensovibep retains Neutralization of omicron variant 12/06/21 Molecular Partners presents results from ensovibep study for COVID-19 patients 12/03/21 Molecular Partners enters MP0533 research collaboration with University of Bern NVS Novartis $90.53 / -0.09 (-0.10%) 01/11/22 Aequus, Sandoz Canada agree to one-year extension on visititan 01/10/22 Sophia Genetics names Abhimanyu Verma as Chief Technology Officer 01/10/22 Molecular Partners, Novartis report Part A of EMPATHY trial met primary endpoint 01/06/22 Alnylam announces pact with Novartis to explore targeted therapy for ESLD MOLN NVS MOLN Molecular Partners $31.61 / +3.515 (+12.51%) 01/14/22 Credit Suisse Molecular Partners price target raised to CHF 23 from CHF 17 at Credit Suisse 01/14/22 SVB Leerink Molecular Partners price target raised to $42 from $35 at SVB Leerink 08/10/21 Credit Suisse Molecular Partners price target lowered to CHF 18.50 at Credit Suisse 07/12/21 Cowen Molecular Partners initiated with an Outperform at Cowen NVS Novartis $90.53 / -0.09 (-0.10%) 01/12/22 Alliance Global Partners OpGen price target lowered to $3 from $4.35 at Alliance Global Partners 01/10/22 Citi Novartis resumed with a Buy at Citi 01/06/22 Piper Sandler Piper want to own Alnylam shares ahead of expected vutrisiran approval 12/15/21 Berenberg Novartis price target lowered to CHF 85 from CHF 88 at Berenberg NVS NVS Novartis $90.53 / -0.09 (-0.10%) 10/26/21 Novartis reports Q3 core EPS $1.71, consensus $1.65 07/21/21 Novartis continues to expect FY21 core operating income to grow mid single digit 07/21/21 Novartis reports Q2 core EPS $1.66, consensus $1.52 16 Jun NVS NVS Novartis $90.53 / -0.09 (-0.10%) 12/06/21 Novartis at work on pan-coronavirus oral treatment, Reuters reports 11/22/21 Novartis plans new sales strategy for cholesterol drug launch, WSJ reports 11/19/21 EQT, Struengmann family weigh Sandoz offer, Reuters reports 11/12/21 Biden to nominate Robert Califf to lead FDA, Politico reports NVS NVS Novartis $90.53 / -0.09 (-0.10%) 12/16/21 Fly Intel: Pre-market Movers 09/20/21 Wall Street in Fives - Must Read Lists for Monday 09/20/21 Wall Street in Fives - Must Read Lists at Midday 07/21/21 Wall Street in Fives - Must Read Lists at Midday 01/21/22 Healthcare 01/20/22 ASCO Gastrointestinal Cancers Symposium 02/02/22 Transplantation & Cellular Therapy Meetings of ASTCT & CIBMTR NVS NVS Novartis $90.53 / -0.09 (-0.10%) 10/04/21 Novartis put volume heavy and directionally bearish
Downgrade	Nordea Bank downgraded to Hold from Buy at Pareto » 05:33 01/18/22 01/18 05:33 01/18/22 05:33 NRDBY Nordea Bank $12.87 / -0.24 (-1.83%) Pareto analyst Herman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NRDBY Nordea Bank $12.87 / -0.24 (-1.83%) 07/30/21 Diana Shipping signs supplemental agreement with Nordea Bank NRDBY Nordea Bank $12.87 / -0.24 (-1.83%) 12/15/21 Credit Suisse Nordea Bank downgraded to Neutral from Outperform at Credit Suisse 11/01/21 Barclays Nordea Bank price target raised to EUR 11.20 from EUR 10.50 at Barclays 10/25/21 UBS Nordea Bank price target raised to SEK 120 from SEK 115 at UBS 10/22/21 Credit Suisse Nordea Bank price target raised to EUR 12 from EUR 11 at Credit Suisse

Upgrade	Swedbank upgraded to Buy from Hold at Pareto » 05:32 01/18/22 01/18 05:32 01/18/22 05:32 SWDBY Swedbank $20.50 / -0.17 (-0.82%) Pareto analyst Herman… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SWDBY Swedbank $20.50 / -0.17 (-0.82%) 11/29/21 Morgan Stanley Swedbank downgraded to Equal Weight from Overweight at Morgan Stanley 11/01/21 Barclays Swedbank price target raised to SEK 204 from SEK 192 at Barclays 10/25/21 JPMorgan Swedbank price target raised to SEK 200 from SEK 195 at JPMorgan 10/22/21 Credit Suisse Swedbank price target raised to SEK 165 from SEK 160 at Credit Suisse
Downgrade	LyondellBasell downgraded to Neutral from Overweight at Atlantic Equities » 05:32 01/18/22 01/18 05:32 01/18/22 05:32 LYB LyondellBasell $102.81 / +1.49 (+1.47%) Atlantic Equities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LYB LyondellBasell $102.81 / +1.49 (+1.47%) 12/13/21 LyondellBasell appoints Peter Vanacker as CEO 11/04/21 PureCycle Technologies names Lawrence Somma as CFO 10/29/21 LyondellBasell says margins are likely to moderate 10/20/21 Wendy's, LyondellBasell collaborate to improve cup recyclability LYB LyondellBasell $102.81 / +1.49 (+1.47%) 11/03/21 RBC Capital LyondellBasell price target lowered to $95 from $110 at RBC Capital 11/02/21 BMO Capital LyondellBasell price target lowered to $115 from $128 at BMO Capital 11/02/21 Wells Fargo LyondellBasell price target lowered to $120 from $127 at Wells Fargo 11/02/21 Deutsche Bank LyondellBasell price target lowered to $100 from $108 at Deutsche Bank LYB LyondellBasell $102.81 / +1.49 (+1.47%) 10/29/21 LyondellBasell reports Q3 EPS $5.25, consensus $5.75 07/30/21 LyondellBasell reports Q2 EPS $6.13, consensus $5.11
Hot Stocks	Best Inc. receives noncompliance notification from NYSE » 05:31 01/18/22 01/18 05:31 01/18/22 05:31 BEST Best Inc. / + Best Inc. announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Options BEST Best Inc. / + 10/29/21 Best Inc. to sell express delivery business in China to J&T Express for $600M 08/02/21 Best Inc. partners with Cainiao to launch cross-border logistics services BEST Best Inc. / + 11/16/21 BEST Inc options imply 35.0% move in share price post-earnings 09/27/21 Largest borrow rate increases among liquid names
Downgrade	Aviva downgraded to Hold from Buy at Investec » 05:31 01/18/22 01/18 05:31 01/18/22 05:31 AVVIY Aviva $11.97 / +0.09 (+0.76%) Investec analyst Ben… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research AVVIY Aviva $11.97 / +0.09 (+0.76%) 09/27/21 Franklin Resources to acquire investment grade credit team from Aviva Investors AVVIY Aviva $11.97 / +0.09 (+0.76%) 01/05/22 Deutsche Bank Aviva named Top Pick among European Insurers at Deutsche Bank 12/13/21 Morgan Stanley Aviva price target raised to 460 GBp from 450 GBp at Morgan Stanley 09/10/21 Barclays Aviva price target raised to 505 GBp from 467 GBp at Barclays 08/16/21 Morgan Stanley Aviva price target raised to 450 GBp from 440 GBp at Morgan Stanley
Upgrade	Sabre Insurance upgraded to Buy from Add at Investec » 05:30 01/18/22 01/18 05:30 01/18/22 05:30 SBIGY Sabre Insurance / + Investec analyst Ben… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Upgrade	Phoenix Group upgraded to Buy from Add at Investec » 05:29 01/18/22 01/18 05:29 01/18/22 05:29 PNXGF Phoenix Group $8.90 / + (+0.00%) Investec analyst Ben… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PNXGF Phoenix Group $8.90 / + (+0.00%) 12/13/21 Morgan Stanley Phoenix Group downgraded to Equal Weight from Overweight at Morgan Stanley 11/15/21 UBS Phoenix Group initiated with a Neutral at UBS 09/30/21 Goldman Sachs Phoenix Group initiated with a Neutral at Goldman Sachs 09/17/21 Credit Suisse Phoenix Group price target raised to 900 GBp from 880 GBp at Credit Suisse
Hot Stocks	Kosmos completes drilling of Winterfell-2 appraisal well » 05:29 01/18/22 01/18 05:29 01/18/22 05:29 KOS Kosmos $4.58 / +0.08 (+1.78%) Kosmos announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events KOS Kosmos $4.58 / +0.08 (+1.78%) 11/11/21 Kosmos says Tullow Oil, PetroSA intend to exercise pre-emption rights 11/08/21 Kosmos falls -7.7% 10/13/21 Kosmos acquires additional Ghana interests for $550M KOS Kosmos $4.58 / +0.08 (+1.78%) 11/11/21 Barclays Kosmos upgraded to Overweight from Equal Weight at Barclays 10/15/21 Berenberg Kosmos upgraded to Buy from Hold at Berenberg 06/21/21 Bernstein Kosmos upgraded to Outperform from Market Perform at Bernstein 06/08/21 Johnson Rice Kosmos upgraded to Buy from Accumulate at Johnson Rice KOS Kosmos $4.58 / +0.08 (+1.78%) 08/09/21 Kosmos reports Q2 EPS (14c), consensus 5c 15 Oct KOS Kosmos $4.58 / +0.08 (+1.78%) 11/11/21 Wall Street in Fives - Must Read Lists for Thursday 11/11/21 Wall Street in Fives - Must Read Lists at Midday 02/27/22 27th Annual Energy Summit
Downgrade	Ovintiv downgraded to Neutral from Overweight at JPMorgan » 05:29 01/18/22 01/18 05:29 01/18/22 05:29 OVV Ovintiv $41.32 / +2.61 (+6.74%) JPMorgan analyst Arun… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events OVV Ovintiv $41.32 / +2.61 (+6.74%) 11/15/21 Appaloosa takes stake in Walmart, exits position in Netflix 11/02/21 Ovintiv says to maintain production in FY22 in line with second half of FY21 09/28/21 Ovintiv receives regulatory approvals for share buy-back program 07/27/21 Ovintiv raises dividend 50% to 14c OVV Ovintiv $41.32 / +2.61 (+6.74%) 01/14/22 Truist Ovintiv price target raised to $53 from $50 at Truist 01/13/22 Scotiabank Ovintiv upgraded to Outperform on 'enhanced' returns at Scotiabank 01/13/22 Scotiabank Ovintiv upgraded to Outperform from Sector Perform at Scotiabank 01/03/22 Mizuho Ovintiv price target lowered to $54 from $56 at Mizuho OVV Ovintiv $41.32 / +2.61 (+6.74%) 11/04/21 Ovintiv reports Q3 EPS (28c) with net losses on risk management 07/27/21 Ovintiv reports Q2 EPS (79c) with items, consensus $1.04 OVV Ovintiv $41.32 / +2.61 (+6.74%) 12/06/21 The Five Stocks David Tepper Is Betting Big On 02/27/22 27th Annual Energy Summit
Recommendations	Traeger, Freshpet, Driven Brands named top retail ideas at Baird » 05:27 01/18/22 01/18 05:27 01/18/22 05:27 COOK Traeger $10.55 / -0.205 (-1.91%) , FRPT Freshpet $91.09 / -5.04 (-5.24%) , DRVN Driven Brands $31.77 / -0.63 (-1.94%) Baird analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options COOK FRPT DRVN COOK Traeger $10.55 / -0.205 (-1.91%) 11/22/21 Traeger CEO: Cost of transportation has hit us particularly hard 09/10/21 Traeger falls -8.8% 09/10/21 Traeger falls -7.0% FRPT Freshpet $91.09 / -5.04 (-5.24%) 12/17/21 Freshpet down 12% at $83.75 after cutting FY21 guidance on supply chain issues 11/30/21 Freshpet CEO buys $200K in common stock 07/19/21 Freshpet EVP, manufacturing & supply chain Stephen Weise to retire DRVN Driven Brands $31.77 / -0.63 (-1.94%) 01/04/22 Driven Brands acquires Auto Glass Now for $170M 01/04/22 Driven Brands expands auto glass offering into US 11/01/21 Driven Brands expands to over 300 car washes in US 10/04/21 Driven Brands appoints Matt Meier as chief digital, data officer COOK FRPT DRVN COOK Traeger $10.55 / -0.205 (-1.91%) 11/16/21 Credit Suisse Traeger price target lowered to $28 from $33 at Credit Suisse 11/16/21 Baird Traeger price target lowered to $25 from $32 at Baird 08/30/21 Fly Intel: Top five analyst initiations 08/30/21 BMO Capital Traeger initiated with an Outperform at BMO Capital FRPT Freshpet $91.09 / -5.04 (-5.24%) 01/11/22 Baird Freshpet deserve a fresh look and buy the pullback, says Baird 01/10/22 Cowen Freshpet price target lowered to $182 from $229 at Cowen 01/05/22 BofA Beyond Meat price target lowered to $55 from $70 at BofA 12/20/21 Truist Freshpet price target lowered to $130 from $175 at Truist DRVN Driven Brands $31.77 / -0.63 (-1.94%) 01/07/22 Piper Sandler Piper announces top five hardlines and leisure picks for 2022 10/29/21 Fly Intel: Top five analyst upgrades 10/29/21 Morgan Stanley Morgan Stanley upgrades 'high growth compounder' Driven Brands to Overweight 10/29/21 Morgan Stanley Driven Brands upgraded to Overweight from Equal Weight at Morgan Stanley COOK FRPT DRVN COOK Traeger $10.55 / -0.205 (-1.91%) 11/15/21 Trager backs FY21 revenue view of $760M-$770M, consensus $764.8M 11/15/21 Traeger reports Q3 adjusted EPS (6c), consensus (8c) 09/09/21 Traeger sees FY21 revenue $760M-$770M, consensus $754.82M 09/09/21 Traeger reports Q2 adjusted EPS 15c, consensus 4c FRPT Freshpet $91.09 / -5.04 (-5.24%) 01/10/22 Freshpet sees 2021 revenue $425.5M, consensus $430.82M 01/10/22 Freshpet sees Q4 revenue $115.9M, consensus $122.21M. 12/17/21 Freshpet cuts FY21 revenue view to $425M-$430M from $445M 11/08/21 Freshpet updates FY21 revenue view to approximately $445M, from at least $445M DRVN Driven Brands $31.77 / -0.63 (-1.94%) 10/27/21 Driven Brands sees FY21 adjusted EPS 84c, consensus 82c 10/27/21 Driven Brands reports Q3 adjusted EPS 26c, consensus 22c 07/28/21 Driven Brands raises FY21 adjusted EPS 83c up from 65c, consensus 66c 07/28/21 Driven Brands reports Q2 adjuted EPS 25c, consensus 16c 05 Aug 29 Jul 24 Feb COOK FRPT COOK Traeger $10.55 / -0.205 (-1.91%) 11/16/21 Wall Street in Fives - Must Read Lists for Tuesday 11/16/21 Wall Street in Fives - Must Read Lists at Midday 09/09/21 Fly Intel: After-Hours Movers 07/31/21 Opening Day: Robinhood shares fall after IPO FRPT Freshpet $91.09 / -5.04 (-5.24%) 01/05/22 Beyond's KFC, McDonald's launches not enough to turn some analysts bullish 12/17/21 Wall Street in Fives - Must Read Lists for Friday 12/17/21 Wall Street in Fives - Must Read Lists at Midday 11/08/21 Fly Intel: After-Hours Movers COOK COOK Traeger $10.55 / -0.205 (-1.91%) 09/21/21 Largest borrow rate increases among liquid names 08/04/21 new option listings and one option delisting on August 4th
Hot Stocks	Bragg Gaming announces Oryx Gaming secures Casino Interlaken deal » 05:26 01/18/22 01/18 05:26 01/18/22 05:26 BRAG Bragg Gaming $4.69 / +0.05 (+1.08%) Oryx Gaming, a Bragg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options BRAG Bragg Gaming $4.69 / +0.05 (+1.08%) 01/07/22 Oryx Gaming adds content to SkillOnNet casino brands in the UK 01/05/22 Bragg Gaming announces Oryx Gaming introduces content in the UK 11/22/21 Oryx Gaming granted UK supplier license 11/17/21 Bragg Gaming announces Oryx Gaming launches platform in Dutch market BRAG Bragg Gaming $4.69 / +0.05 (+1.08%) 11/09/21 Canaccord Bragg Gaming price target lowered to C$21 from C$30 at Canaccord BRAG Bragg Gaming $4.69 / +0.05 (+1.08%) 01/07/22 Bet On It: New York ushers in mobile sports betting in time for NFL playoffs 11/18/21 Rising High: Exclusive talk with cannabis company Tyson 2.0 BRAG Bragg Gaming $4.69 / +0.05 (+1.08%) 10/13/21 Nine new option listings on October 13th

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Empire State Manufacturing Index: January 2022 Government Event
FTCI
Today at 08:30

FTC Solar - FTCI Conference Calls
PNC
Today at 09:30

PNC Financial - PNC Conference Calls
GS
Today at 09:30

Goldman Sachs - GS Conference Calls
Today at 10:00

Housing Market Index: January 2022 Government Event
Today at 10:00

Business & Information Services Industry Meetings
MSFT ...
Today at 10:00

Technology Industry Meetings
TFC
Today at 10:30

Truist Financial - TFC Conference Calls
Today at 11:00

4-Week Bill Announcement Government Event
Today at 11:00

8-Week Bill Announcement Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	JUNS X JUNS Jupiter Neurosciences IPO Managers: Roth Capital & Desjardins $5.00-7.00 3.333M Shares
Tues	No deals
Wed	FSPR X FSPR Four Springs Capital IPO Managers: Morgan Stanley, Goldman Sachs & Wells Fargo, Mizuho, Scotiabank, Nomura, Berenberg $13.00-15.00 18M Shares RHDM X RHDM Rhodium Enterprises IPO Managers: B. Riley & Cowen, Needham, DA Davidson, Northland $12.00-14.00 7.692M Shares
Thurs	SMSA X SMSA Samsara Vision IPO Managers: ThinkEquity $5.00-7.00 28.75M Shares
Fri	No deals

View All Syndicate Announcements »

Porch announces newest pay-at-close module for home inspection companies

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access